Home
BIO
BIO News

Latest Bio-Rad Laboratories Inc. (BIO) News on January 22, 2025

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Zacks

5 days ago

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right Now

Zacks

5 days ago

Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right Now

Argus Research

7 days ago

BIO: Raising target price to $294.00

MT Newswires

14 days ago

Bio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

Business Wire

14 days ago

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference

Business Wire

19 days ago

Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference

At US$331, Is It Time To Put Bio-Rad Laboratories, Inc. (NYSE:BIO) On Your Watch List?

Simply Wall St.

a month ago

At US$331, Is It Time To Put Bio-Rad Laboratories, Inc. (NYSE:BIO) On Your Watch List?

Argus Research

a month ago

BIO: Rating increased to a HOLD

Argus Research

a month ago

BIO: Lowering target price to $277.00

Argus Research

a month ago

BIO: Lowering target price to $278.00

MT Newswires

a month ago

RBC Raises Price Target on Bio-Rad Laboratories to $481 From $469, Keeps Outperform Rating

Argus Research

2 months ago

BIO: Raising target price to $291.00

Bio-Rad (BIO) Down 5.5% Since Last Earnings Report: Can It Rebound?

Zacks

2 months ago

Bio-Rad (BIO) Down 5.5% Since Last Earnings Report: Can It Rebound?

Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)

Simply Wall St.

2 months ago

Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)

Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory

Insider Monkey

2 months ago

Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory

Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

Business Wire

2 months ago

Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity?

Insider Monkey

2 months ago

What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity?

Argus Research

2 months ago

BIO: Lowering target price to $292.00

Argus Research

3 months ago

BIO: Raising target price to $299.00

Interpreting Bio-Rad (BIO) International Revenue Trends

Zacks

3 months ago

Interpreting Bio-Rad (BIO) International Revenue Trends

Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.

3 months ago

Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023)

Simply Wall St.

3 months ago

Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023)

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Bio Rad Laboratories Inc Earnings Call

Morningstar Research

3 months ago

Analyst Report: Bio-Rad Laboratories, Inc.

MT Newswires

3 months ago

UBS Adjusts Price Target on Bio-Rad Laboratories to $390 From $400, Maintains Buy Rating

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

Business Wire

3 months ago

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket

Zacks

3 months ago

BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket

Bio-Rad Laboratories Inc (BIO) Q3 2024 Earnings Call Highlights: Strong Clinical Diagnostics ...

GuruFocus.com

3 months ago

Bio-Rad Laboratories Inc (BIO) Q3 2024 Earnings Call Highlights: Strong Clinical Diagnostics ...

Bio-Rad Laboratories (BIO) Beats Q3 Earnings and Revenue Estimates

Zacks

3 months ago

Bio-Rad Laboratories (BIO) Beats Q3 Earnings and Revenue Estimates

Associated Press Finance

3 months ago

Bio-Rad: Q3 Earnings Snapshot

Bio-Rad Reports Third-Quarter 2024 Financial Results

Business Wire

3 months ago

Bio-Rad Reports Third-Quarter 2024 Financial Results

What to Expect From These 3 MedTech Stocks This Earnings Season

Zacks

3 months ago

What to Expect From These 3 MedTech Stocks This Earnings Season

Shareholders in Bio-Rad Laboratories (NYSE:BIO) have lost 58%, as stock drops 4.6% this past week

Simply Wall St.

3 months ago

Shareholders in Bio-Rad Laboratories (NYSE:BIO) have lost 58%, as stock drops 4.6% this past week

Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for

Zacks

3 months ago

Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for

FitLife Brands (FTLF) Soars 5.7%: Is Further Upside Left in the Stock?

Zacks

3 months ago

FitLife Brands (FTLF) Soars 5.7%: Is Further Upside Left in the Stock?

BIO Gears Up for Q3 Earnings: Here's What You Need to Know

Zacks

3 months ago

BIO Gears Up for Q3 Earnings: Here's What You Need to Know

Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund

Insider Monkey

3 months ago

Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

Business Wire

3 months ago

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

BANK OF NOVA SCOTIA's Strategic Acquisition in Bio-Rad Laboratories Inc

GuruFocus.com

3 months ago

BANK OF NOVA SCOTIA's Strategic Acquisition in Bio-Rad Laboratories Inc

Argus Research

3 months ago

BIO: Raising target price to $274.00

Should You Continue to Hold Bio-Rad Stock in Your Portfolio?

Zacks

4 months ago

Should You Continue to Hold Bio-Rad Stock in Your Portfolio?

MT Newswires

4 months ago

Citigroup Upgrades Bio-Rad Laboratories to Buy From Neutral, Adjusts Price Target to $400 From $350

Palantir Soars, Dell Pops As Big AI Plays Finally Get S&P 500 Nod

Investor's Business Daily

4 months ago

Palantir Soars, Dell Pops As Big AI Plays Finally Get S&P 500 Nod

Palantir and Dell Will Join S&P 500—What You Need To Know

Investopedia

4 months ago

Palantir and Dell Will Join S&P 500—What You Need To Know

Palantir Stock Jumps on S&P 500 Addition. Here’s Who Else Was Added.

Barrons.com

4 months ago

Palantir Stock Jumps on S&P 500 Addition. Here’s Who Else Was Added.

Palantir, Dell Will Finally Join The S&P 500. The Stocks Are Jumping.

Investor's Business Daily

4 months ago

Palantir, Dell Will Finally Join The S&P 500. The Stocks Are Jumping.

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

PR Newswire

4 months ago

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Palantir, Dell Stocks Jump on S&P 500 Addition

Barrons.com

4 months ago

Palantir, Dell Stocks Jump on S&P 500 Addition

National Vision (EYE) Down 6.9% Since Last Earnings Report: Can It Rebound?

Zacks

5 months ago

National Vision (EYE) Down 6.9% Since Last Earnings Report: Can It Rebound?

MT Newswires

5 months ago

Wells Fargo Initiates Bio-Rad Laboratories at Equalweight With $340 Price Target

Argus Research

5 months ago

BIO: Raising target price to $283.00

Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference

Business Wire

5 months ago

Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference

Reasons to Retain Bio-Rad (BIO) Stock in Your Portfolio Now

Zacks

5 months ago

Reasons to Retain Bio-Rad (BIO) Stock in Your Portfolio Now

Argus Research

5 months ago

BIO: What does Argus have to say about BIO?

MT Newswires

5 months ago

Bio-Rad Laboratories Names Jon DiVincenzo COO

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

Business Wire

5 months ago

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

Bio-Rad (BIO) Faces Low BioPharma Demand, Competitive Pressure

Zacks

5 months ago

Bio-Rad (BIO) Faces Low BioPharma Demand, Competitive Pressure

Bio-Rad Laboratories, Inc. (BIO): Should You Invest In This Organ Transplant and Diagnosis Stock Right Now?

Insider Monkey

5 months ago

Bio-Rad Laboratories, Inc. (BIO): Should You Invest In This Organ Transplant and Diagnosis Stock Right Now?

MT Newswires

6 months ago

Citigroup Adjusts Price Target on Bio-Rad Laboratories to $350 From $300

MT Newswires

6 months ago

UBS Adjusts Price Target on Bio-Rad Laboratories to $400 From $385, Maintains Buy Rating

Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Guidance Lowered

Zacks

6 months ago

Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Guidance Lowered

MT Newswires

6 months ago

RBC Trims Price Target on Bio-Rad Laboratories to $401 From $402, Keeps Outperform Rating

MT Newswires

6 months ago

Bio-Rad Laboratories Q2 Earnings Up, Revenue Lower; Updates Guidance; Shares Fall After-Hours

Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings Estimates

Zacks

6 months ago

Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings Estimates

Associated Press Finance

6 months ago

Bio-Rad: Q2 Earnings Snapshot

Bio-Rad Reports Second-Quarter 2024 Financial Results

Business Wire

6 months ago

Bio-Rad Reports Second-Quarter 2024 Financial Results

What's in Store for These 4 MedTech Stocks in Q2 Earnings?

Zacks

6 months ago

What's in Store for These 4 MedTech Stocks in Q2 Earnings?

All You Need to Know About Bio-Rad (BIO) Rating Upgrade to Buy

Zacks

6 months ago

All You Need to Know About Bio-Rad (BIO) Rating Upgrade to Buy

Bio-Rad Laboratories’ (BIO) Growth Tailwinds Are Delayed, Not Derailed

Insider Monkey

6 months ago

Bio-Rad Laboratories’ (BIO) Growth Tailwinds Are Delayed, Not Derailed

Argus Research

6 months ago

BIO: Lowering target price to $275.00

Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?

Zacks

6 months ago

Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

Business Wire

6 months ago

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

Argus Research

6 months ago

BIO: Raising target price to $283.00

Argus Research

6 months ago

BIO: Raising target price to $220.00

MT Newswires

7 months ago

RBC Trims Price Target on Bio-Rad Laboratories to $402 From $414, Keeps Outperform Rating

Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now?

Zacks

7 months ago

Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now?

Is Bio-Rad Laboratories (BIO) a Lucrative Investment?

Insider Monkey

7 months ago

Is Bio-Rad Laboratories (BIO) a Lucrative Investment?

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

7 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

7 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

7 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

7 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

7 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

7 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

7 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

7 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

GuruFocus.com

7 months ago

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

Insider Sale: CFO Steven Tomsic Sells 30,000 Shares of Fox Corp (FOX)

GuruFocus.com

7 months ago

Insider Sale: CFO Steven Tomsic Sells 30,000 Shares of Fox Corp (FOX)

Insider Sale: Chief Legal Officer Jeff Lendino Sells Shares of Jamf Holding Corp (JAMF)

GuruFocus.com

7 months ago

Insider Sale: Chief Legal Officer Jeff Lendino Sells Shares of Jamf Holding Corp (JAMF)

Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)

GuruFocus.com

7 months ago

Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)

Insider Sale: SVP & Chief Accounting Officer Dara Bazzano Sells 4,300 Shares of T-Mobile US ...

GuruFocus.com

7 months ago

Insider Sale: SVP & Chief Accounting Officer Dara Bazzano Sells 4,300 Shares of T-Mobile US ...

What's Going On With Rivian Stock?

Motley Fool

7 months ago

What's Going On With Rivian Stock?

Director and 10% Owner Telekom Deutsche Sells Shares of T-Mobile US Inc (TMUS)

GuruFocus.com

7 months ago

Director and 10% Owner Telekom Deutsche Sells Shares of T-Mobile US Inc (TMUS)

Insider Sale: Director Donna Wells Sells Shares of Mitek Systems Inc (MITK)

GuruFocus.com

7 months ago

Insider Sale: Director Donna Wells Sells Shares of Mitek Systems Inc (MITK)

Phibro (PAHC) Down 3.3% Since Last Earnings Report: Can It Rebound?

Zacks

7 months ago

Phibro (PAHC) Down 3.3% Since Last Earnings Report: Can It Rebound?

Why Is Bio-Rad (BIO) Up 7.8% Since Last Earnings Report?

Zacks

8 months ago

Why Is Bio-Rad (BIO) Up 7.8% Since Last Earnings Report?

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

Business Wire

8 months ago

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

Business Wire

8 months ago

Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

Thomson Reuters StreetEvents

8 months ago

Q1 2024 OncoCyte Corp Earnings Call

Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its First-Quarter Results

Simply Wall St.

8 months ago

Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its First-Quarter Results

Morningstar Research

8 months ago

Analyst Report: Bio-Rad Laboratories, Inc.

Share on Social Networks: